Physician profile
Frederick J Reed
NPI 1467411157
$1,665.74
in general payments reported to CMS, 2019-2025
17 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $291 · 2021: $65.27 · 2022: $207 · 2023: $285 · 2024: $262 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $665.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $394.56 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $321.85 | 2019-2024 | Xarelto |
| Amgen INC. | $276.68 | 2019-2024 | Prolia, Evenity |
| Novo Nordisk INC | $222.54 | 2019-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $166.25 | 2019-2025 | Farxiga, Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $50.84 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.14 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $36.28 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.20 | 2019 | |
| Lilly USA, LLC | $23.85 | 2019-2020 | |
| Sanofi Pasteur INC. | $22.14 | 2019 | |
| Abbvie INC. | $21.41 | 2024 | |
| Glaxosmithkline, LLC. | $15.11 | 2023 | Shingrix |
| Merck Sharp & Dohme LLC | $12.99 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.98 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $11.79 | 2019 | |
| Amarin Pharma, INC. | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.